Inventor · disambiguated record
Dann Parker
Also filed as: PARKER DANN · PARKER DANN L · PARKER DANN L JR · PARKER DANN LEROY
22 granted patents·2 pending applications·76 citations·filing 2001–2018
92Inventor score
Top patents by PatentIndex Score
24 records- 0191US8188085B2Antifungal agentsGREENLEE MARK L·Filed 2009·Granted May 29, 2012·24 cites·51 claims
- 0284US10086000B2Tricyclic compounds as inhibitors of mutant IDH enzymesMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·3 cites·17 claims
- 0383US7157604B2Selective estrogen receptor modulatorsMERCK & CO INC·Filed 2002·Granted Jan 2, 2007·20 cites·22 claims
- 0481US7087599B2Estrogen receptor modulatorsMERCK & CO INC·Filed 2001·Granted Aug 8, 2006·15 cites·27 claims
- 0579US8722727B2Antifungal agentsGREENLEE MARK L·Filed 2009·Granted May 13, 2014·2 cites·35 claims
- 0678US9796733B2Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activatorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 24, 2017·4 cites·18 claims
- 0777US9834563B2Antidiabetic substituted heteroaryl compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 5, 2017·4 cites·13 claims
- 0875US10213429B2Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activatorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 26, 2019·2 cites·18 claims
- 0971US7923568B2Estrogen receptor modulatorsMERCK SHARP & DOHME·Filed 2006·Granted Apr 12, 2011·1 cites·8 claims
- 1065US10508108B2Tricyclic compounds as inhibitors of mutant IDH enzymesMERCK SHARP & DOHME·Filed 2015·Granted Dec 17, 2019·1 cites·20 claims
- 1155US10144741B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Granted Dec 4, 2018·0 cites·13 claims
- 1252US9944654B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·0 cites·15 claims
- 1349US2005137192A1Estrogen receptor modulatorsFiled 2005·Application pending·0 cites
- 1445US7432284B2Estrogen receptor modulatorsMERCK & CO INC·Filed 2003·Granted Oct 7, 2008·0 cites·6 claims
- 1542US10472344B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Nov 12, 2019·0 cites·10 claims
- 1640US10287269B2Pyrazolyl pyrimidinone compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted May 14, 2019·0 cites·19 claims
- 1740US10189819B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 29, 2019·0 cites·14 claims
- 1837US10245264B2Substituted imidazo[1,2-a]pyrazines as soluble guanylate cyclase activatorsMERCK SHARP & DOHME·Filed 2016·Granted Apr 2, 2019·0 cites·18 claims
- 1936US9914736B2TrKA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Mar 13, 2018·0 cites·14 claims
- 2036US9808445B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 7, 2017·0 cites·19 claims
- 2135US10351558B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jul 16, 2019·0 cites·11 claims
- 2234US10442819B2Tricyclic compounds as inhibitors of mutant IDH enzymesFISCHER CHRISTIAN·Filed 2015·Granted Oct 15, 2019·0 cites·16 claims
- 2332US2007293706A1Synthesis Of 1,5-Disubstituted-2-Hydroxy-Gibbatetraen-6-OnesWILKENING ROBERT R·Filed 2005·Application pending·0 cites
- 2430US9969724B2Factor IXa inhibitorsSAKURADA ISAO·Filed 2015·Granted May 15, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Dann Parker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →